4//SEC Filing
Kay Mark A 4
Accession 0000899243-18-027227
CIK 0001664106other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 9:20 PM ET
Size
5.3 KB
Accession
0000899243-18-027227
Insider Transaction Report
Form 4
Kay Mark A
Director
Transactions
- Award
Stock Option (right to buy)
2018-10-18+24,102→ 24,102 totalExercise: $10.00Exp: 2028-10-17→ Common Stock (24,102 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, October 18, 2018.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001752537
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 9:20 PM ET
- Size
- 5.3 KB